Ad is loading...
CSSCX
Price
$23.12
Change
+$0.46 (+2.03%)
Updated
Nov 22 closing price
VISVX
Price
$51.30
Change
+$0.69 (+1.36%)
Updated
Nov 22 closing price
Ad is loading...

CSSCX vs VISVX

Header iconCSSCX vs VISVX Comparison
Open Charts CSSCX vs VISVXBanner chart's image
Columbia Small Cap Value I C
Price$23.12
Change+$0.46 (+2.03%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$51.30
Change+$0.69 (+1.36%)
VolumeN/A
CapitalizationN/A
CSSCX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSSCX vs. VISVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSSCX is a StrongBuy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. CSSCX (1.63B). VISVX pays higher dividends than CSSCX: VISVX (1.90) vs CSSCX (0.00). CSSCX was incepted earlier than VISVX: CSSCX (29 years) vs VISVX (27 years). CSSCX is a more actively managed with annual turnover of: 72.00 vs. VISVX (16.00). CSSCX has a lower initial minimum investment than VISVX: CSSCX (2000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 30.04 vs. CSSCX (4.62). VISVX return over 5 years is better than : 62.14 vs. CSSCX (3.38).
CSSCXVISVXCSSCX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years27 years-
Gain YTD2.44117.71214%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets1.63B57.6B3%
Annual Yield % from dividends0.001.90-
Returns for 1 year4.6230.0415%
Returns for 3 years-26.2816.92-155%
Returns for 5 years3.3862.145%
Returns for 10 years-42.88109.83-39%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics